| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Histone Acetyltransferases | 42 | 2009 | 312 | 3.890 |
Why?
|
| Trans-Activators | 29 | 2009 | 805 | 3.010 |
Why?
|
| Transcription Factors | 40 | 2012 | 2580 | 2.970 |
Why?
|
| Nuclear Receptor Coactivator 3 | 39 | 2013 | 346 | 2.710 |
Why?
|
| Nuclear Receptor Coactivator 1 | 37 | 2014 | 243 | 2.340 |
Why?
|
| Twist-Related Protein 1 | 5 | 2013 | 36 | 1.870 |
Why?
|
| Breast Neoplasms | 13 | 2014 | 2478 | 1.140 |
Why?
|
| Nuclear Receptor Coactivators | 9 | 2013 | 72 | 1.130 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 10 | 2011 | 392 | 1.100 |
Why?
|
| Mice | 86 | 2014 | 17624 | 1.090 |
Why?
|
| Mice, Knockout | 44 | 2013 | 3777 | 0.970 |
Why?
|
| Nuclear Proteins | 8 | 2013 | 1280 | 0.970 |
Why?
|
| Insulin-Like Growth Factor I | 10 | 2011 | 339 | 0.970 |
Why?
|
| Animals | 103 | 2014 | 33870 | 0.920 |
Why?
|
| Nuclear Receptor Coactivator 2 | 16 | 2013 | 203 | 0.830 |
Why?
|
| Mammary Neoplasms, Experimental | 4 | 2011 | 245 | 0.820 |
Why?
|
| Mammary Glands, Animal | 13 | 2013 | 482 | 0.800 |
Why?
|
| Prostatic Neoplasms | 6 | 2013 | 1513 | 0.800 |
Why?
|
| Estradiol | 7 | 2012 | 534 | 0.790 |
Why?
|
| Gene Expression Regulation | 18 | 2012 | 2539 | 0.760 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2013 | 1881 | 0.710 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 5 | 2007 | 551 | 0.680 |
Why?
|
| Uterus | 8 | 2012 | 595 | 0.640 |
Why?
|
| Receptors, Steroid | 5 | 2004 | 269 | 0.620 |
Why?
|
| Neoplasms | 5 | 2013 | 2697 | 0.590 |
Why?
|
| Neoplasm Metastasis | 2 | 2010 | 653 | 0.560 |
Why?
|
| Embryonic Stem Cells | 4 | 2009 | 172 | 0.560 |
Why?
|
| Embryo, Mammalian | 5 | 2010 | 453 | 0.560 |
Why?
|
| Neoplasm Invasiveness | 4 | 2011 | 602 | 0.550 |
Why?
|
| Liver | 19 | 2013 | 1855 | 0.550 |
Why?
|
| Macrophage Colony-Stimulating Factor | 2 | 2014 | 22 | 0.550 |
Why?
|
| Estrogen Receptor alpha | 5 | 2012 | 449 | 0.520 |
Why?
|
| Mice, Transgenic | 18 | 2014 | 2438 | 0.520 |
Why?
|
| Cell Movement | 5 | 2011 | 838 | 0.520 |
Why?
|
| Gene Expression | 16 | 2013 | 1589 | 0.500 |
Why?
|
| Alternative Splicing | 5 | 2011 | 346 | 0.480 |
Why?
|
| Cell Proliferation | 11 | 2013 | 2321 | 0.470 |
Why?
|
| Adenocarcinoma | 3 | 2013 | 997 | 0.470 |
Why?
|
| Hair Follicle | 1 | 2013 | 33 | 0.440 |
Why?
|
| Health | 1 | 2013 | 36 | 0.440 |
Why?
|
| Prostate | 3 | 2012 | 423 | 0.420 |
Why?
|
| Mice, Inbred C57BL | 22 | 2013 | 4385 | 0.420 |
Why?
|
| Morphogenesis | 5 | 2013 | 213 | 0.410 |
Why?
|
| Signal Transduction | 17 | 2013 | 4518 | 0.410 |
Why?
|
| Repressor Proteins | 8 | 2011 | 813 | 0.400 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2012 | 355 | 0.400 |
Why?
|
| Placentation | 2 | 2010 | 54 | 0.400 |
Why?
|
| Estrogens | 6 | 2012 | 505 | 0.400 |
Why?
|
| RNA, Messenger | 17 | 2012 | 2829 | 0.400 |
Why?
|
| Tumor Suppressor Proteins | 2 | 2012 | 465 | 0.400 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2011 | 207 | 0.400 |
Why?
|
| Growth | 2 | 2004 | 107 | 0.390 |
Why?
|
| Paracrine Communication | 1 | 2012 | 71 | 0.390 |
Why?
|
| Integrin alpha5 | 1 | 2011 | 5 | 0.380 |
Why?
|
| Mesoderm | 1 | 2011 | 116 | 0.370 |
Why?
|
| Embryo Implantation | 2 | 2012 | 230 | 0.370 |
Why?
|
| Homeodomain Proteins | 2 | 2012 | 547 | 0.370 |
Why?
|
| Cell Line, Tumor | 10 | 2014 | 3297 | 0.370 |
Why?
|
| Spermatogenesis | 2 | 2009 | 163 | 0.370 |
Why?
|
| Organ Specificity | 6 | 2013 | 427 | 0.360 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 2 | 2008 | 55 | 0.360 |
Why?
|
| Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2010 | 11 | 0.360 |
Why?
|
| Transcription, Genetic | 12 | 2009 | 1703 | 0.360 |
Why?
|
| Epithelial Cells | 4 | 2012 | 907 | 0.360 |
Why?
|
| Serine | 1 | 2011 | 175 | 0.350 |
Why?
|
| Receptors, Estrogen | 9 | 2011 | 788 | 0.350 |
Why?
|
| Aging | 3 | 2013 | 1164 | 0.350 |
Why?
|
| Cell Transformation, Neoplastic | 3 | 2011 | 629 | 0.350 |
Why?
|
| RNA, Small Interfering | 6 | 2014 | 664 | 0.340 |
Why?
|
| Cyclic AMP Response Element Modulator | 1 | 2009 | 25 | 0.340 |
Why?
|
| Female | 45 | 2014 | 64573 | 0.340 |
Why?
|
| Jumonji Domain-Containing Histone Demethylases | 1 | 2009 | 28 | 0.330 |
Why?
|
| Antigens, Polyomavirus Transforming | 2 | 2009 | 89 | 0.310 |
Why?
|
| Promoter Regions, Genetic | 9 | 2010 | 1351 | 0.310 |
Why?
|
| Immunohistochemistry | 10 | 2010 | 1710 | 0.310 |
Why?
|
| Cell Division | 5 | 2004 | 793 | 0.300 |
Why?
|
| Reproduction | 5 | 2007 | 237 | 0.300 |
Why?
|
| Matrix Metalloproteinase 2 | 1 | 2008 | 94 | 0.300 |
Why?
|
| Apoptosis | 10 | 2013 | 1791 | 0.300 |
Why?
|
| Transcriptional Activation | 7 | 2011 | 483 | 0.300 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 2008 | 137 | 0.300 |
Why?
|
| Receptors, Progesterone | 5 | 2006 | 865 | 0.290 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2007 | 59 | 0.290 |
Why?
|
| Estrogen Receptor beta | 2 | 2007 | 78 | 0.290 |
Why?
|
| Growth Hormone | 3 | 2006 | 150 | 0.280 |
Why?
|
| Lung Neoplasms | 4 | 2014 | 1582 | 0.280 |
Why?
|
| Genetic Techniques | 1 | 2007 | 102 | 0.280 |
Why?
|
| Testis | 4 | 2005 | 401 | 0.280 |
Why?
|
| Receptors, Retinoic Acid | 3 | 2010 | 101 | 0.280 |
Why?
|
| Receptors, Growth Factor | 3 | 1996 | 35 | 0.280 |
Why?
|
| Infertility, Male | 1 | 2009 | 257 | 0.270 |
Why?
|
| Carotid Artery Injuries | 2 | 2007 | 39 | 0.270 |
Why?
|
| Cell Culture Techniques | 2 | 2005 | 288 | 0.270 |
Why?
|
| Tunica Intima | 2 | 2007 | 59 | 0.270 |
Why?
|
| E2F1 Transcription Factor | 1 | 2006 | 47 | 0.270 |
Why?
|
| Histones | 1 | 2009 | 528 | 0.260 |
Why?
|
| Blotting, Western | 6 | 2011 | 1105 | 0.260 |
Why?
|
| Pituitary Gland | 6 | 2005 | 84 | 0.260 |
Why?
|
| Ovariectomy | 5 | 2007 | 180 | 0.260 |
Why?
|
| Male | 35 | 2013 | 59243 | 0.250 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2011 | 217 | 0.250 |
Why?
|
| Fibroblast Growth Factors | 9 | 2012 | 154 | 0.240 |
Why?
|
| Fibroblasts | 5 | 2005 | 882 | 0.240 |
Why?
|
| Cell Line | 12 | 2012 | 2787 | 0.240 |
Why?
|
| RNA Interference | 5 | 2014 | 497 | 0.240 |
Why?
|
| Receptors, Androgen | 4 | 2013 | 408 | 0.240 |
Why?
|
| Antineoplastic Agents, Hormonal | 3 | 2011 | 254 | 0.240 |
Why?
|
| Biomarkers, Tumor | 1 | 2012 | 1414 | 0.230 |
Why?
|
| Growth Disorders | 1 | 2006 | 208 | 0.230 |
Why?
|
| Thyroid Hormones | 6 | 2005 | 66 | 0.230 |
Why?
|
| Humans | 47 | 2014 | 121793 | 0.230 |
Why?
|
| Nervous System | 1 | 2004 | 128 | 0.230 |
Why?
|
| Sertoli Cells | 1 | 2004 | 75 | 0.230 |
Why?
|
| Genes, ras | 1 | 2004 | 96 | 0.230 |
Why?
|
| Molecular Sequence Data | 14 | 2011 | 3886 | 0.220 |
Why?
|
| Mice, Mutant Strains | 6 | 2007 | 388 | 0.220 |
Why?
|
| Disease Progression | 5 | 2009 | 1984 | 0.220 |
Why?
|
| Receptors, Fibroblast Growth Factor | 9 | 1996 | 60 | 0.210 |
Why?
|
| Cerebellar Cortex | 1 | 2003 | 20 | 0.210 |
Why?
|
| Receptors, Thyroid Hormone | 4 | 2003 | 84 | 0.210 |
Why?
|
| Mammary Neoplasms, Animal | 3 | 2008 | 137 | 0.210 |
Why?
|
| Cell Differentiation | 5 | 2010 | 1933 | 0.210 |
Why?
|
| Protein Structure, Tertiary | 5 | 2012 | 750 | 0.200 |
Why?
|
| Amino Acid Sequence | 13 | 2011 | 2700 | 0.200 |
Why?
|
| Receptor, ErbB-2 | 3 | 2011 | 496 | 0.200 |
Why?
|
| DNA-Binding Proteins | 5 | 2007 | 2032 | 0.190 |
Why?
|
| Mammary Tumor Virus, Mouse | 2 | 2014 | 106 | 0.190 |
Why?
|
| Purkinje Cells | 1 | 2003 | 156 | 0.190 |
Why?
|
| Amino Acid Motifs | 5 | 2010 | 198 | 0.190 |
Why?
|
| Crosses, Genetic | 5 | 2011 | 160 | 0.190 |
Why?
|
| Hepatocytes | 4 | 2011 | 257 | 0.180 |
Why?
|
| Phosphorylation | 9 | 2011 | 1616 | 0.180 |
Why?
|
| Lymphatic Metastasis | 2 | 2014 | 396 | 0.180 |
Why?
|
| Sexual Maturation | 1 | 2000 | 48 | 0.180 |
Why?
|
| Ovary | 1 | 2003 | 390 | 0.170 |
Why?
|
| Body Weight | 6 | 2012 | 931 | 0.170 |
Why?
|
| Motor Activity | 1 | 2003 | 494 | 0.170 |
Why?
|
| Biomedical Research | 1 | 2005 | 508 | 0.170 |
Why?
|
| Antibodies | 5 | 2009 | 371 | 0.160 |
Why?
|
| Immunoblotting | 2 | 2011 | 312 | 0.160 |
Why?
|
| Cadherins | 2 | 2010 | 164 | 0.160 |
Why?
|
| Transfection | 7 | 2010 | 1076 | 0.160 |
Why?
|
| Placenta | 1 | 2002 | 496 | 0.150 |
Why?
|
| Triiodothyronine | 6 | 2003 | 63 | 0.150 |
Why?
|
| Glucose | 4 | 2013 | 875 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 6 | 2010 | 1300 | 0.150 |
Why?
|
| Genitalia, Male | 1 | 1998 | 37 | 0.150 |
Why?
|
| Organ Size | 5 | 2009 | 406 | 0.150 |
Why?
|
| Cells, Cultured | 9 | 2012 | 3075 | 0.150 |
Why?
|
| Gonadal Steroid Hormones | 1 | 1998 | 83 | 0.150 |
Why?
|
| HeLa Cells | 5 | 2011 | 807 | 0.150 |
Why?
|
| Growth Substances | 2 | 1995 | 113 | 0.150 |
Why?
|
| Tumor Cells, Cultured | 7 | 2007 | 1073 | 0.140 |
Why?
|
| Receptors, Transforming Growth Factor beta | 2 | 1996 | 109 | 0.140 |
Why?
|
| Embryo Loss | 2 | 2010 | 26 | 0.140 |
Why?
|
| Prealbumin | 2 | 2008 | 27 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2013 | 492 | 0.140 |
Why?
|
| Genetic Variation | 2 | 1994 | 1460 | 0.140 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 3 | 1996 | 133 | 0.140 |
Why?
|
| Amino Acid Substitution | 3 | 2012 | 390 | 0.130 |
Why?
|
| Polymerase Chain Reaction | 6 | 2010 | 1590 | 0.130 |
Why?
|
| Bone and Bones | 3 | 2007 | 262 | 0.130 |
Why?
|
| Exons | 5 | 2006 | 793 | 0.130 |
Why?
|
| Gene Targeting | 4 | 2005 | 183 | 0.130 |
Why?
|
| Receptors, Cell Surface | 3 | 1992 | 471 | 0.130 |
Why?
|
| Protein Binding | 10 | 2012 | 1736 | 0.130 |
Why?
|
| Protein Isoforms | 4 | 2011 | 410 | 0.130 |
Why?
|
| Inhibins | 2 | 1995 | 94 | 0.130 |
Why?
|
| Base Sequence | 11 | 2006 | 3117 | 0.120 |
Why?
|
| Mice, Inbred Strains | 2 | 2008 | 317 | 0.120 |
Why?
|
| Steroidogenic Factor 1 | 2 | 2012 | 31 | 0.120 |
Why?
|
| Protein-Tyrosine Kinases | 3 | 2008 | 212 | 0.120 |
Why?
|
| Thyroid Hormone Receptors alpha | 3 | 2003 | 14 | 0.120 |
Why?
|
| Retinoid X Receptors | 2 | 2004 | 33 | 0.120 |
Why?
|
| Poly A | 1 | 1994 | 59 | 0.120 |
Why?
|
| Acetyltransferases | 3 | 2003 | 91 | 0.120 |
Why?
|
| Disease Models, Animal | 5 | 2010 | 4306 | 0.120 |
Why?
|
| Pregnancy | 6 | 2011 | 7045 | 0.120 |
Why?
|
| Genotype | 5 | 2009 | 2483 | 0.120 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2010 | 715 | 0.120 |
Why?
|
| Protein Stability | 2 | 2011 | 168 | 0.120 |
Why?
|
| Macrophage Activation | 1 | 2014 | 62 | 0.110 |
Why?
|
| MAP Kinase Kinase 4 | 2 | 2011 | 36 | 0.110 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2014 | 64 | 0.110 |
Why?
|
| Oncogene Proteins | 3 | 2003 | 138 | 0.110 |
Why?
|
| Ligands | 4 | 2004 | 534 | 0.110 |
Why?
|
| Transcription Factor AP-1 | 1 | 2014 | 107 | 0.110 |
Why?
|
| Inflammation | 3 | 2012 | 1393 | 0.110 |
Why?
|
| MCF-7 Cells | 1 | 2014 | 222 | 0.110 |
Why?
|
| Protein Conformation | 5 | 2002 | 835 | 0.110 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2014 | 70 | 0.110 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2012 | 513 | 0.110 |
Why?
|
| Cell Dedifferentiation | 1 | 2013 | 21 | 0.110 |
Why?
|
| Orchiectomy | 1 | 2013 | 46 | 0.110 |
Why?
|
| Liver Cirrhosis, Experimental | 2 | 2010 | 6 | 0.110 |
Why?
|
| Gene Dosage | 4 | 2011 | 441 | 0.110 |
Why?
|
| Cloning, Molecular | 7 | 2002 | 900 | 0.110 |
Why?
|
| Drug Resistance | 3 | 2005 | 257 | 0.110 |
Why?
|
| Binding Sites | 6 | 2010 | 1294 | 0.100 |
Why?
|
| Hypoglycemia | 2 | 2012 | 190 | 0.100 |
Why?
|
| Carnitine Acyltransferases | 1 | 2012 | 6 | 0.100 |
Why?
|
| Tumor Burden | 1 | 2013 | 229 | 0.100 |
Why?
|
| Hypertrophy, Left Ventricular | 1 | 2012 | 107 | 0.100 |
Why?
|
| Liver Regeneration | 2 | 2011 | 52 | 0.100 |
Why?
|
| Telomere-Binding Proteins | 1 | 2012 | 46 | 0.100 |
Why?
|
| Hypothalamus | 3 | 2012 | 213 | 0.100 |
Why?
|
| Dietary Fats | 2 | 2010 | 273 | 0.100 |
Why?
|
| Structure-Activity Relationship | 3 | 2010 | 566 | 0.100 |
Why?
|
| Gene Deletion | 5 | 2010 | 798 | 0.100 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2011 | 65 | 0.100 |
Why?
|
| Enzyme Induction | 2 | 2011 | 105 | 0.100 |
Why?
|
| Receptors, Somatotropin | 1 | 2011 | 9 | 0.100 |
Why?
|
| Acrocephalosyndactylia | 1 | 2011 | 22 | 0.100 |
Why?
|
| Cullin Proteins | 1 | 2011 | 13 | 0.100 |
Why?
|
| Muscular Diseases | 1 | 2012 | 103 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2011 | 79 | 0.090 |
Why?
|
| Heparin | 4 | 1995 | 230 | 0.090 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2013 | 269 | 0.090 |
Why?
|
| Enzyme Activation | 3 | 2011 | 620 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2011 | 94 | 0.090 |
Why?
|
| Organogenesis | 1 | 2011 | 78 | 0.090 |
Why?
|
| Disease-Free Survival | 1 | 2013 | 860 | 0.090 |
Why?
|
| Telomere | 1 | 2012 | 205 | 0.090 |
Why?
|
| Retinoblastoma-Binding Protein 7 | 1 | 2010 | 6 | 0.090 |
Why?
|
| NF-kappa B | 2 | 2011 | 462 | 0.090 |
Why?
|
| Protein Transport | 1 | 2012 | 369 | 0.090 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2011 | 111 | 0.090 |
Why?
|
| Histone Deacetylase 2 | 1 | 2010 | 16 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2011 | 128 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2012 | 210 | 0.090 |
Why?
|
| PPAR-beta | 1 | 2010 | 4 | 0.090 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2013 | 428 | 0.090 |
Why?
|
| Metabolome | 1 | 2013 | 290 | 0.090 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2010 | 33 | 0.090 |
Why?
|
| Thyroid Gland | 4 | 2005 | 117 | 0.090 |
Why?
|
| Peritonitis | 1 | 2010 | 76 | 0.090 |
Why?
|
| Body Fat Distribution | 1 | 2010 | 27 | 0.090 |
Why?
|
| Up-Regulation | 2 | 2011 | 872 | 0.090 |
Why?
|
| Cholesterol 7-alpha-Hydroxylase | 2 | 2007 | 36 | 0.090 |
Why?
|
| Macrophages | 1 | 2014 | 612 | 0.090 |
Why?
|
| Gluconeogenesis | 1 | 2010 | 107 | 0.090 |
Why?
|
| Lactation | 1 | 2011 | 186 | 0.090 |
Why?
|
| Subcutaneous Fat | 1 | 2010 | 28 | 0.090 |
Why?
|
| Cell Adhesion | 1 | 2011 | 321 | 0.090 |
Why?
|
| Tamoxifen | 1 | 2011 | 363 | 0.090 |
Why?
|
| Copulation | 1 | 2009 | 10 | 0.090 |
Why?
|
| Intra-Abdominal Fat | 1 | 2010 | 51 | 0.090 |
Why?
|
| Models, Biological | 4 | 2010 | 1437 | 0.090 |
Why?
|
| Spermatocytes | 1 | 2009 | 22 | 0.090 |
Why?
|
| Mice, Nude | 2 | 2011 | 697 | 0.090 |
Why?
|
| Spermatids | 1 | 2009 | 24 | 0.090 |
Why?
|
| Histone Deacetylases | 1 | 2010 | 115 | 0.080 |
Why?
|
| DNA Primers | 4 | 2005 | 668 | 0.080 |
Why?
|
| Autoantigens | 1 | 2010 | 132 | 0.080 |
Why?
|
| Oligospermia | 1 | 2009 | 57 | 0.080 |
Why?
|
| Cell Adhesion Molecules | 1 | 2011 | 226 | 0.080 |
Why?
|
| ErbB Receptors | 1 | 2011 | 281 | 0.080 |
Why?
|
| Ventricular Dysfunction, Left | 1 | 2012 | 366 | 0.080 |
Why?
|
| Bone Density | 3 | 2011 | 305 | 0.080 |
Why?
|
| Androgen-Binding Protein | 1 | 2009 | 22 | 0.080 |
Why?
|
| Smad2 Protein | 1 | 2009 | 50 | 0.080 |
Why?
|
| Microglia | 1 | 2010 | 95 | 0.080 |
Why?
|
| MAP Kinase Signaling System | 1 | 2011 | 319 | 0.080 |
Why?
|
| Fatty Liver | 1 | 2010 | 181 | 0.080 |
Why?
|
| Methylation | 1 | 2009 | 226 | 0.080 |
Why?
|
| Proto-Oncogene Protein c-ets-2 | 1 | 2008 | 8 | 0.080 |
Why?
|
| Smad3 Protein | 1 | 2009 | 55 | 0.080 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2009 | 58 | 0.080 |
Why?
|
| Glucose-6-Phosphatase | 1 | 2008 | 19 | 0.080 |
Why?
|
| Lens, Crystalline | 1 | 2010 | 138 | 0.080 |
Why?
|
| Glycogen Storage Disease Type I | 1 | 2008 | 12 | 0.080 |
Why?
|
| Carrier Proteins | 3 | 2011 | 1022 | 0.080 |
Why?
|
| Recombinant Fusion Proteins | 3 | 2008 | 772 | 0.080 |
Why?
|
| Skin | 1 | 2012 | 506 | 0.080 |
Why?
|
| Phosphotyrosine | 1 | 2008 | 23 | 0.080 |
Why?
|
| PPAR alpha | 2 | 2010 | 54 | 0.080 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2009 | 127 | 0.080 |
Why?
|
| Rabbits | 1 | 2009 | 717 | 0.080 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 2010 | 317 | 0.080 |
Why?
|
| HEK293 Cells | 1 | 2011 | 742 | 0.080 |
Why?
|
| Escherichia coli Infections | 1 | 2010 | 191 | 0.080 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2011 | 347 | 0.080 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 1759 | 0.080 |
Why?
|
| Cytokines | 3 | 2010 | 1284 | 0.080 |
Why?
|
| Wound Healing | 1 | 2012 | 454 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2008 | 372 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 1103 | 0.080 |
Why?
|
| Stem Cells | 3 | 2005 | 710 | 0.070 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2007 | 23 | 0.070 |
Why?
|
| Liver X Receptors | 1 | 2007 | 20 | 0.070 |
Why?
|
| Cholesterol, Dietary | 1 | 2007 | 41 | 0.070 |
Why?
|
| Genes, Reporter | 3 | 2005 | 385 | 0.070 |
Why?
|
| Cytoskeletal Proteins | 1 | 2009 | 270 | 0.070 |
Why?
|
| Mutation, Missense | 1 | 2012 | 840 | 0.070 |
Why?
|
| Mitochondria | 1 | 2012 | 679 | 0.070 |
Why?
|
| Lipogenesis | 1 | 2007 | 59 | 0.070 |
Why?
|
| Drug Resistance, Neoplasm | 2 | 2011 | 714 | 0.070 |
Why?
|
| Recombinant Proteins | 5 | 2010 | 1401 | 0.070 |
Why?
|
| Progesterone | 4 | 2006 | 624 | 0.070 |
Why?
|
| Mutant Proteins | 1 | 2007 | 112 | 0.070 |
Why?
|
| Thyroid Hormone Receptors beta | 5 | 2005 | 19 | 0.070 |
Why?
|
| Microfilament Proteins | 1 | 2009 | 278 | 0.070 |
Why?
|
| Adrenal Glands | 2 | 2005 | 47 | 0.070 |
Why?
|
| Dwarfism | 1 | 2008 | 102 | 0.070 |
Why?
|
| Hormone Antagonists | 2 | 1997 | 63 | 0.070 |
Why?
|
| Lymph Nodes | 1 | 2009 | 377 | 0.070 |
Why?
|
| Mutagenesis, Insertional | 1 | 2007 | 147 | 0.070 |
Why?
|
| Mifepristone | 2 | 1997 | 138 | 0.070 |
Why?
|
| Alleles | 2 | 2008 | 1585 | 0.070 |
Why?
|
| In Situ Hybridization | 1 | 2007 | 472 | 0.070 |
Why?
|
| Probability | 1 | 2007 | 318 | 0.070 |
Why?
|
| Sp1 Transcription Factor | 1 | 2006 | 43 | 0.070 |
Why?
|
| Steroids | 1 | 2007 | 203 | 0.070 |
Why?
|
| Germ-Line Mutation | 1 | 2008 | 303 | 0.070 |
Why?
|
| Glucocorticoids | 1 | 2009 | 379 | 0.070 |
Why?
|
| Lac Operon | 2 | 2005 | 94 | 0.070 |
Why?
|
| Random Allocation | 1 | 2007 | 415 | 0.070 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2006 | 66 | 0.070 |
Why?
|
| Sepsis | 1 | 2010 | 477 | 0.070 |
Why?
|
| Human Growth Hormone | 1 | 2006 | 73 | 0.070 |
Why?
|
| Sex Characteristics | 1 | 2007 | 306 | 0.060 |
Why?
|
| Cell Growth Processes | 1 | 2005 | 63 | 0.060 |
Why?
|
| Reference Values | 1 | 2007 | 693 | 0.060 |
Why?
|
| 9,10-Dimethyl-1,2-benzanthracene | 1 | 2005 | 56 | 0.060 |
Why?
|
| Glucose Tolerance Test | 1 | 2006 | 203 | 0.060 |
Why?
|
| Transformation, Genetic | 1 | 2005 | 36 | 0.060 |
Why?
|
| Transcriptome | 1 | 2011 | 906 | 0.060 |
Why?
|
| Nerve Tissue Proteins | 1 | 2011 | 1113 | 0.060 |
Why?
|
| Survival Rate | 1 | 2010 | 1976 | 0.060 |
Why?
|
| Bile Acids and Salts | 1 | 2007 | 236 | 0.060 |
Why?
|
| Islets of Langerhans | 1 | 2006 | 174 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2005 | 116 | 0.060 |
Why?
|
| Thyrotropin | 5 | 2003 | 58 | 0.060 |
Why?
|
| Hypercholesterolemia | 1 | 2007 | 225 | 0.060 |
Why?
|
| Carcinogens | 1 | 2005 | 155 | 0.060 |
Why?
|
| Epigenesis, Genetic | 1 | 2009 | 659 | 0.060 |
Why?
|
| MyoD Protein | 1 | 2004 | 21 | 0.060 |
Why?
|
| Haploidy | 1 | 2004 | 19 | 0.060 |
Why?
|
| Chromatin Immunoprecipitation | 3 | 2010 | 240 | 0.060 |
Why?
|
| DNA, Complementary | 4 | 2006 | 465 | 0.060 |
Why?
|
| Protein Structure, Quaternary | 1 | 2004 | 98 | 0.060 |
Why?
|
| Stress, Psychological | 1 | 2009 | 546 | 0.060 |
Why?
|
| Baculoviridae | 2 | 1995 | 64 | 0.060 |
Why?
|
| Sperm Count | 1 | 2004 | 75 | 0.060 |
Why?
|
| Feces | 1 | 2007 | 711 | 0.060 |
Why?
|
| Fibroblast Growth Factor 1 | 2 | 1994 | 13 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2007 | 1463 | 0.060 |
Why?
|
| Protein Biosynthesis | 1 | 2007 | 668 | 0.060 |
Why?
|
| Retinoblastoma Protein | 1 | 2003 | 76 | 0.060 |
Why?
|
| Sex Differentiation | 1 | 2003 | 22 | 0.050 |
Why?
|
| Myocardium | 4 | 2013 | 983 | 0.050 |
Why?
|
| Death | 1 | 2004 | 71 | 0.050 |
Why?
|
| Pulmonary Alveoli | 1 | 2004 | 138 | 0.050 |
Why?
|
| Mutation | 2 | 2007 | 5773 | 0.050 |
Why?
|
| Digestive System | 1 | 2003 | 60 | 0.050 |
Why?
|
| Body Constitution | 1 | 2002 | 30 | 0.050 |
Why?
|
| Brain Chemistry | 1 | 2003 | 121 | 0.050 |
Why?
|
| Chromatin | 2 | 2003 | 550 | 0.050 |
Why?
|
| Motor Neurons | 1 | 2003 | 138 | 0.050 |
Why?
|
| Blotting, Southern | 1 | 2002 | 217 | 0.050 |
Why?
|
| Spermatozoa | 1 | 2004 | 227 | 0.050 |
Why?
|
| Ligation | 1 | 2002 | 134 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2005 | 558 | 0.050 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 2009 | 0.050 |
Why?
|
| Introns | 1 | 2002 | 301 | 0.050 |
Why?
|
| Cell Count | 1 | 2002 | 253 | 0.050 |
Why?
|
| Rats | 7 | 2006 | 3659 | 0.050 |
Why?
|
| Cell Membrane | 2 | 1995 | 459 | 0.050 |
Why?
|
| RNA Splicing | 2 | 1993 | 223 | 0.050 |
Why?
|
| Spinal Cord | 1 | 2003 | 302 | 0.050 |
Why?
|
| Androgens | 1 | 2003 | 257 | 0.050 |
Why?
|
| Carcinoma, Hepatocellular | 4 | 2009 | 959 | 0.050 |
Why?
|
| Insulin | 1 | 2006 | 1189 | 0.050 |
Why?
|
| Phylogeny | 1 | 2003 | 684 | 0.050 |
Why?
|
| Phenotype | 3 | 2010 | 4200 | 0.050 |
Why?
|
| Proteins | 2 | 2005 | 1039 | 0.050 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 446 | 0.050 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2002 | 239 | 0.050 |
Why?
|
| Cell Nucleus | 4 | 2012 | 679 | 0.050 |
Why?
|
| Fetal Growth Retardation | 1 | 2002 | 222 | 0.040 |
Why?
|
| Plasmids | 2 | 2003 | 516 | 0.040 |
Why?
|
| Retinoic Acid Receptor alpha | 2 | 2010 | 19 | 0.040 |
Why?
|
| Behavior, Animal | 1 | 2003 | 477 | 0.040 |
Why?
|
| Fatty Acids | 2 | 2013 | 338 | 0.040 |
Why?
|
| Models, Genetic | 1 | 2002 | 740 | 0.040 |
Why?
|
| Liver Neoplasms | 4 | 2009 | 1380 | 0.040 |
Why?
|
| Muscle, Skeletal | 3 | 2013 | 928 | 0.040 |
Why?
|
| Macromolecular Substances | 2 | 2002 | 186 | 0.040 |
Why?
|
| Collagen | 2 | 2012 | 312 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2002 | 514 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 1995 | 657 | 0.040 |
Why?
|
| Macrophages, Peritoneal | 2 | 2010 | 38 | 0.040 |
Why?
|
| Pro-Opiomelanocortin | 2 | 2012 | 90 | 0.040 |
Why?
|
| Activin Receptors | 2 | 1996 | 17 | 0.040 |
Why?
|
| Lipid Metabolism | 2 | 2012 | 354 | 0.040 |
Why?
|
| Activins | 2 | 1995 | 78 | 0.040 |
Why?
|
| Binding, Competitive | 2 | 1995 | 179 | 0.040 |
Why?
|
| Stromal Cells | 2 | 2012 | 296 | 0.040 |
Why?
|
| Tretinoin | 2 | 2010 | 117 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 1008 | 0.040 |
Why?
|
| Thyroxine | 3 | 2002 | 63 | 0.040 |
Why?
|
| Conserved Sequence | 2 | 1995 | 293 | 0.040 |
Why?
|
| Brain | 2 | 2013 | 2941 | 0.030 |
Why?
|
| Cholesterol | 3 | 2005 | 507 | 0.030 |
Why?
|
| Chromosome Mapping | 1 | 1999 | 1064 | 0.030 |
Why?
|
| Time Factors | 2 | 2005 | 6168 | 0.030 |
Why?
|
| Response Elements | 2 | 2008 | 99 | 0.030 |
Why?
|
| Spodoptera | 1 | 1995 | 44 | 0.030 |
Why?
|
| Gene Transfer Techniques | 1 | 1997 | 374 | 0.030 |
Why?
|
| Proteoglycans | 2 | 2012 | 93 | 0.030 |
Why?
|
| Fasting | 2 | 2008 | 299 | 0.030 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2008 | 261 | 0.030 |
Why?
|
| Transforming Growth Factor beta | 2 | 1994 | 460 | 0.030 |
Why?
|
| Epitopes | 1 | 1996 | 429 | 0.030 |
Why?
|
| Thyrotropin, beta Subunit | 2 | 2003 | 4 | 0.030 |
Why?
|
| Green Fluorescent Proteins | 2 | 2005 | 392 | 0.030 |
Why?
|
| Testosterone | 1 | 1998 | 462 | 0.030 |
Why?
|
| Precipitin Tests | 3 | 2003 | 153 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2007 | 569 | 0.030 |
Why?
|
| Kinetics | 1 | 1995 | 1316 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2010 | 1675 | 0.030 |
Why?
|
| RNA, Small Cytoplasmic | 1 | 2012 | 2 | 0.030 |
Why?
|
| Cystine | 1 | 1992 | 15 | 0.030 |
Why?
|
| Thyroid Function Tests | 2 | 2003 | 20 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2009 | 284 | 0.030 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 1992 | 35 | 0.030 |
Why?
|
| Protein Sorting Signals | 1 | 2012 | 38 | 0.030 |
Why?
|
| Phenols | 1 | 2012 | 57 | 0.030 |
Why?
|
| Insecta | 1 | 1992 | 57 | 0.030 |
Why?
|
| Ketosis | 1 | 2012 | 15 | 0.030 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 1992 | 54 | 0.030 |
Why?
|
| Plasma | 1 | 2013 | 96 | 0.030 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1992 | 287 | 0.030 |
Why?
|
| Bone Demineralization, Pathologic | 1 | 2011 | 3 | 0.030 |
Why?
|
| Skin Physiological Phenomena | 1 | 2012 | 19 | 0.020 |
Why?
|
| Oxidative Phosphorylation | 1 | 2012 | 93 | 0.020 |
Why?
|
| Laminin | 1 | 2012 | 59 | 0.020 |
Why?
|
| Ventricular Remodeling | 1 | 2012 | 175 | 0.020 |
Why?
|
| Hyperammonemia | 1 | 2012 | 60 | 0.020 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2011 | 58 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 145 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2007 | 669 | 0.020 |
Why?
|
| Skin Transplantation | 1 | 2012 | 60 | 0.020 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 86 | 0.020 |
Why?
|
| Protein Kinases | 1 | 1993 | 330 | 0.020 |
Why?
|
| Xenobiotics | 1 | 2011 | 26 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 2012 | 288 | 0.020 |
Why?
|
| Oxygen Consumption | 1 | 2012 | 304 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2011 | 99 | 0.020 |
Why?
|
| Heterozygote | 2 | 2005 | 679 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2012 | 263 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 444 | 0.020 |
Why?
|
| G1 Phase | 1 | 2011 | 67 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2011 | 215 | 0.020 |
Why?
|
| Hep G2 Cells | 1 | 2010 | 92 | 0.020 |
Why?
|
| gamma-Crystallins | 1 | 2010 | 4 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-maf | 1 | 2010 | 10 | 0.020 |
Why?
|
| Acetaminophen | 1 | 2011 | 92 | 0.020 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2010 | 29 | 0.020 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 198 | 0.020 |
Why?
|
| Proteolysis | 1 | 2011 | 168 | 0.020 |
Why?
|
| Corticosterone | 1 | 2010 | 61 | 0.020 |
Why?
|
| Liver Neoplasms, Experimental | 1 | 2010 | 66 | 0.020 |
Why?
|
| Transgenes | 1 | 2011 | 336 | 0.020 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2010 | 123 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2012 | 301 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2010 | 744 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 2010 | 89 | 0.020 |
Why?
|
| Microphthalmos | 1 | 2010 | 55 | 0.020 |
Why?
|
| Caspase 3 | 1 | 2010 | 130 | 0.020 |
Why?
|
| Systems Biology | 1 | 2010 | 60 | 0.020 |
Why?
|
| Amino Acids | 1 | 2013 | 659 | 0.020 |
Why?
|
| COUP Transcription Factor II | 1 | 2010 | 117 | 0.020 |
Why?
|
| Pyridines | 1 | 2011 | 222 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 123 | 0.020 |
Why?
|
| Adiponectin | 1 | 2010 | 107 | 0.020 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2011 | 279 | 0.020 |
Why?
|
| Phagocytosis | 1 | 2010 | 170 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2010 | 351 | 0.020 |
Why?
|
| Carbon Tetrachloride | 1 | 2009 | 7 | 0.020 |
Why?
|
| Colforsin | 1 | 2009 | 49 | 0.020 |
Why?
|
| Hepatic Stellate Cells | 1 | 2009 | 20 | 0.020 |
Why?
|
| Phosphothreonine | 1 | 2009 | 5 | 0.020 |
Why?
|
| Interleukin-3 | 1 | 2009 | 17 | 0.020 |
Why?
|
| Reactive Oxygen Species | 1 | 2012 | 480 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 2010 | 133 | 0.020 |
Why?
|
| Phosphoserine | 1 | 2009 | 41 | 0.020 |
Why?
|
| Adipocytes | 1 | 2010 | 158 | 0.020 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2009 | 45 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2009 | 134 | 0.020 |
Why?
|
| Models, Molecular | 1 | 1992 | 1069 | 0.020 |
Why?
|
| Mammals | 1 | 2010 | 263 | 0.020 |
Why?
|
| Peptides | 1 | 1992 | 799 | 0.020 |
Why?
|
| Liver Glycogen | 1 | 2008 | 25 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2010 | 326 | 0.020 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 1 | 2009 | 110 | 0.020 |
Why?
|
| Adiposity | 1 | 2010 | 177 | 0.020 |
Why?
|
| Necrosis | 1 | 2009 | 212 | 0.020 |
Why?
|
| Amygdala | 1 | 2009 | 75 | 0.020 |
Why?
|
| Central Nervous System | 1 | 2010 | 255 | 0.020 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 2008 | 41 | 0.020 |
Why?
|
| Protein Interaction Mapping | 1 | 2008 | 85 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2011 | 744 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2010 | 994 | 0.020 |
Why?
|
| Heart Ventricles | 1 | 2012 | 767 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2008 | 122 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2010 | 371 | 0.020 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2007 | 52 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2010 | 808 | 0.020 |
Why?
|
| Myocytes, Cardiac | 1 | 2012 | 618 | 0.020 |
Why?
|
| Cataract | 1 | 2010 | 217 | 0.020 |
Why?
|
| Body Composition | 1 | 2010 | 472 | 0.020 |
Why?
|
| T-Cell Intracellular Antigen-1 | 1 | 2007 | 7 | 0.020 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2007 | 55 | 0.020 |
Why?
|
| Fibrosis | 1 | 2009 | 429 | 0.020 |
Why?
|
| Epithelium | 1 | 2008 | 373 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2011 | 1078 | 0.020 |
Why?
|
| Genes, p53 | 1 | 2007 | 215 | 0.020 |
Why?
|
| Cell Survival | 1 | 2009 | 817 | 0.020 |
Why?
|
| Rats, Mutant Strains | 1 | 2006 | 14 | 0.020 |
Why?
|
| Rats, Inbred OLETF | 1 | 2006 | 7 | 0.020 |
Why?
|
| Receptors, Glucocorticoid | 1 | 2007 | 123 | 0.020 |
Why?
|
| Phosphoenolpyruvate Carboxykinase (ATP) | 1 | 2005 | 7 | 0.020 |
Why?
|
| Triglycerides | 1 | 2008 | 547 | 0.020 |
Why?
|
| Acute Disease | 1 | 2009 | 1088 | 0.020 |
Why?
|
| Adrenocorticotropic Hormone | 1 | 2005 | 78 | 0.020 |
Why?
|
| Ovulation | 1 | 2006 | 112 | 0.020 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2010 | 387 | 0.020 |
Why?
|
| Restraint, Physical | 1 | 2005 | 28 | 0.020 |
Why?
|
| Shock, Septic | 1 | 2007 | 148 | 0.020 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2005 | 93 | 0.020 |
Why?
|
| Myometrium | 1 | 2005 | 48 | 0.020 |
Why?
|
| DNA | 2 | 2006 | 1606 | 0.020 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 2005 | 15 | 0.020 |
Why?
|
| Lipopolysaccharides | 1 | 2007 | 292 | 0.020 |
Why?
|
| Luciferases | 1 | 2005 | 137 | 0.020 |
Why?
|
| Insulin Resistance | 1 | 2010 | 629 | 0.020 |
Why?
|
| Infertility, Female | 1 | 2006 | 165 | 0.020 |
Why?
|
| Complement C3 | 1 | 2005 | 47 | 0.020 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 2 | 1996 | 66 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2004 | 119 | 0.020 |
Why?
|
| In Vitro Techniques | 1 | 2006 | 968 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1996 | 462 | 0.010 |
Why?
|
| Lactoferrin | 1 | 2005 | 77 | 0.010 |
Why?
|
| Haplorhini | 2 | 1995 | 127 | 0.010 |
Why?
|
| Dexamethasone | 1 | 2005 | 274 | 0.010 |
Why?
|
| Dimerization | 1 | 2004 | 144 | 0.010 |
Why?
|
| Hypothermia | 1 | 2004 | 51 | 0.010 |
Why?
|
| Immunoglobulins | 2 | 1995 | 169 | 0.010 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2003 | 39 | 0.010 |
Why?
|
| Models, Animal | 1 | 2005 | 466 | 0.010 |
Why?
|
| Bone Development | 1 | 2003 | 57 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2003 | 157 | 0.010 |
Why?
|
| Thyroid Hormone Resistance Syndrome | 1 | 2003 | 5 | 0.010 |
Why?
|
| Saccharomyces cerevisiae Proteins | 1 | 2005 | 274 | 0.010 |
Why?
|
| Absorptiometry, Photon | 1 | 2003 | 168 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 150 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2006 | 1214 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 2511 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1993 | 135 | 0.010 |
Why?
|
| Molecular Weight | 2 | 1994 | 393 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2005 | 528 | 0.010 |
Why?
|
| Osteoporosis | 1 | 2003 | 114 | 0.010 |
Why?
|
| Interferon Regulatory Factor-1 | 1 | 2002 | 15 | 0.010 |
Why?
|
| Cell Fractionation | 1 | 2002 | 38 | 0.010 |
Why?
|
| Creatine Kinase | 1 | 2002 | 54 | 0.010 |
Why?
|
| I-kappa B Kinase | 1 | 2002 | 61 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2002 | 112 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1993 | 314 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2002 | 260 | 0.010 |
Why?
|
| Alkaline Phosphatase | 1 | 2002 | 96 | 0.010 |
Why?
|
| Kidney | 1 | 2008 | 1343 | 0.010 |
Why?
|
| Blood Glucose | 1 | 2005 | 1095 | 0.010 |
Why?
|
| Caspases | 1 | 2002 | 160 | 0.010 |
Why?
|
| Hormones | 1 | 2002 | 189 | 0.010 |
Why?
|
| Leptin | 1 | 2002 | 205 | 0.010 |
Why?
|
| Hypothyroidism | 1 | 2002 | 88 | 0.010 |
Why?
|
| Haplotypes | 1 | 2002 | 507 | 0.010 |
Why?
|
| Homozygote | 1 | 2002 | 533 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2002 | 399 | 0.010 |
Why?
|
| Nuclear Respiratory Factors | 1 | 1999 | 8 | 0.010 |
Why?
|
| Weight Gain | 1 | 2002 | 372 | 0.010 |
Why?
|
| Heart Rate | 1 | 2002 | 583 | 0.010 |
Why?
|
| E1A-Associated p300 Protein | 1 | 1999 | 53 | 0.010 |
Why?
|
| COS Cells | 1 | 1999 | 273 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2002 | 999 | 0.010 |
Why?
|
| Energy Metabolism | 1 | 2002 | 742 | 0.010 |
Why?
|
| Nerve Growth Factors | 1 | 1997 | 72 | 0.010 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 4 | 1 | 1996 | 14 | 0.010 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2003 | 2031 | 0.010 |
Why?
|
| Models, Structural | 1 | 1995 | 49 | 0.010 |
Why?
|
| Dipeptides | 1 | 1995 | 56 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1994 | 129 | 0.010 |
Why?
|
| Cell Compartmentation | 1 | 1994 | 42 | 0.010 |
Why?
|
| Cytoskeleton | 1 | 1996 | 178 | 0.010 |
Why?
|
| Phosphopeptides | 1 | 1993 | 27 | 0.010 |
Why?
|
| Moths | 1 | 1993 | 22 | 0.010 |
Why?
|
| Heparitin Sulfate | 1 | 1993 | 20 | 0.010 |
Why?
|
| Trypsin | 1 | 1993 | 95 | 0.010 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 1993 | 17 | 0.010 |
Why?
|
| RNA, Neoplasm | 1 | 1993 | 138 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 1993 | 97 | 0.010 |
Why?
|
| DNA, Antisense | 1 | 1992 | 8 | 0.010 |
Why?
|
| Metalloendopeptidases | 1 | 1993 | 101 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 1992 | 189 | 0.010 |
Why?
|
| Disulfides | 1 | 1992 | 78 | 0.010 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 1993 | 124 | 0.010 |
Why?
|
| DNA, Neoplasm | 1 | 1993 | 301 | 0.010 |
Why?
|
| Lysine | 1 | 1993 | 200 | 0.010 |
Why?
|
| Keratinocytes | 1 | 1992 | 60 | 0.010 |
Why?
|
| Cattle | 1 | 1993 | 559 | 0.010 |
Why?
|
| Cell Cycle | 1 | 1994 | 619 | 0.010 |
Why?
|
| Endothelium | 1 | 1992 | 73 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1993 | 354 | 0.010 |
Why?
|
| Cadaverine | 1 | 1991 | 4 | 0.010 |
Why?
|
| Staurosporine | 1 | 1991 | 21 | 0.010 |
Why?
|
| Electrophoresis, Gel, Two-Dimensional | 1 | 1991 | 42 | 0.010 |
Why?
|
| Chloroquine | 1 | 1991 | 32 | 0.010 |
Why?
|
| Biotin | 1 | 1991 | 41 | 0.010 |
Why?
|
| Alkaloids | 1 | 1991 | 32 | 0.010 |
Why?
|
| Cross-Linking Reagents | 1 | 1991 | 55 | 0.010 |
Why?
|
| Temperature | 1 | 1991 | 304 | 0.010 |
Why?
|
| Antibodies, Monoclonal | 1 | 1993 | 1021 | 0.000 |
Why?
|